Headline Daily News_the failure of TACE surgical treatment in patients with liver cancer_ Switching to targeted drugs can help control the condition 17/10/2024 liver cancer Gene therapy
Hong Kong's first stereo positioning radiation therapy + immunotherapy combination therapy, a new hope for liver cancer patients 21/06/2022 liver cancer
The disease control rate of liver cancer is nearly 60%! Remolumab Cyramza targeted treatment results are eye-catching 21/06/2022 liver cancer Cyramza gene
Research|First-line treatment of advanced liver cancer with carbotinib and atelizumab reduces the risk of disease progression 37% 20/06/2022 liver cancer RET gene, PD-L1 gene
The efficiency is nearly 80%! The latest clinical data of the NTRK targeted drug Larotrectinib Larotrectinib released 20/06/2022 Lung cancer NTRK gene
Research|First-line treatment of advanced liver cancer with carbotinib and atelizumab reduces the risk of disease progression 37% 15/06/2022 liver cancer RET gene
Hong Kong's first stereo positioning radiation therapy + immunotherapy combination therapy, a new hope for liver cancer patients 09/06/2022 liver cancer FGFR
Research|First-line treatment of advanced liver cancer with carbotinib and atelizumab reduces the risk of disease progression 37% 08/06/2022 liver cancer c-Met, VEGFR2, and AXL and RET
